Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV001000913 | SCV001158000 | uncertain significance | Autosomal recessive nonsyndromic hearing loss 79 | 2018-11-28 | criteria provided, single submitter | clinical testing | The TPRN c.1696C>T; p.Leu566Phe variant (rs201404168), to our knowledge, is not reported in the medical literature or gene specific databases. This variant is found in the non-Finnish European population with an allele frequency of 0.0071% (8/112,546 alleles) in the Genome Aggregation Database. The leucine at codon 566 is highly conserved, and computational analyses (SIFT, PolyPhen-2) predict that this variant is deleterious. Due to limited information, the clinical significance of the p.Leu566Phe variant is uncertain at this time. |
Ambry Genetics | RCV002550742 | SCV003736381 | uncertain significance | Inborn genetic diseases | 2022-11-21 | criteria provided, single submitter | clinical testing | The c.1696C>T (p.L566F) alteration is located in exon 1 (coding exon 1) of the TPRN gene. This alteration results from a C to T substitution at nucleotide position 1696, causing the leucine (L) at amino acid position 566 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |